179942-55-3 Usage
Uses
Used in Pharmaceutical Industry:
4-(2H-TETRAZOL-5-YL)-PHENYLBORONIC ACID is used as a reactant for palladium-catalyzed carbon-carbon bond formation in the Suzuki-Miyaura reaction, which is a widely employed method for the synthesis of biologically active compounds, including pharmaceuticals. The Suzuki-Miyaura reaction allows for the formation of new carbon-carbon bonds between an aryl or vinyl boronic acid and an aryl or vinyl halide or triflate, enabling the creation of complex molecular structures with potential therapeutic applications.
Used in Chemical Synthesis:
4-(2H-TETRAZOL-5-YL)-PHENYLBORONIC ACID is used as a building block in the synthesis of various organic compounds, including heterocycles, natural products, and materials with specific properties. The tetrazole ring provides unique reactivity and stability, making it a valuable component in the design and synthesis of novel molecules with potential applications in various fields, such as medicine, agrochemistry, and materials science.
Used in Research and Development:
4-(2H-TETRAZOL-5-YL)-PHENYLBORONIC ACID is utilized as a research tool in the development of new synthetic methods and catalysts for cross-coupling reactions. Its unique reactivity and the ability to form stable intermediates make it an attractive candidate for the design of new catalysts and ligands that can improve the efficiency and selectivity of palladium-catalyzed reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 179942-55-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,9,9,4 and 2 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 179942-55:
(8*1)+(7*7)+(6*9)+(5*9)+(4*4)+(3*2)+(2*5)+(1*5)=193
193 % 10 = 3
So 179942-55-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H7BN4O2/c13-8(14)6-3-1-5(2-4-6)7-9-11-12-10-7/h1-4,13-14H,(H,9,10,11,12)
179942-55-3Relevant articles and documents
2-METHYLMORPHOLINE PYRIDO-, PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS
-
Page/Page column 109, (2008/06/13)
There is provided a compound of Formula (I), or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula (1), and the use of a compound of Formula (1) as a medicament and in the treatment of cancer